855 related articles for article (PubMed ID: 16959581)
21. [Arterial hypertension in diabetes mellitus].
Tiengo A
G Clin Med; 1990 Jan; 71(1):3-6, 10-6. PubMed ID: 2142112
[No Abstract] [Full Text] [Related]
22. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
Re RN
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
[TBL] [Abstract][Full Text] [Related]
23. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin-aldosterone system in diabetes mellitus.
Christlieb AR
Diabetes; 1976; 25(2 SUPPL):820-5. PubMed ID: 823063
[TBL] [Abstract][Full Text] [Related]
25. Renin-angiotensin-system blockade in the prevention of diabetes.
Ostergren J
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
[TBL] [Abstract][Full Text] [Related]
26. [RAAS and insulin resistance].
Motoshima H; Araki E
Nihon Rinsho; 2012 Sep; 70(9):1542-9. PubMed ID: 23012801
[TBL] [Abstract][Full Text] [Related]
27. Hypertension and renal complications in type 2 diabetes.
Nosadini R
Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
[TBL] [Abstract][Full Text] [Related]
28. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
Duprez DA
J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
[TBL] [Abstract][Full Text] [Related]
29. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
31. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
[TBL] [Abstract][Full Text] [Related]
32. Role of aldosterone and angiotensin II in insulin resistance: an update.
Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
[TBL] [Abstract][Full Text] [Related]
33. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
Ferrannini E; Seghieri G; Muscelli E
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S61-9. PubMed ID: 7700069
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the renal renin-angiotensin system and renoprotection by pitavastatin in type1 diabetes.
Toba H; Mitani T; Takahashi T; Imai N; Serizawa R; Wang J; Kobara M; Nakata T
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1064-70. PubMed ID: 20678154
[TBL] [Abstract][Full Text] [Related]
35. Hypertension in diabetes mellitus.
Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
[No Abstract] [Full Text] [Related]
36. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
37. Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population.
Afghahi H; Miftaraj M; Svensson AM; Hadimeri H; Gudbjörnsdottir S; Eliasson B; Svensson MK;
J Diabetes Complications; 2013; 27(3):229-34. PubMed ID: 23246248
[TBL] [Abstract][Full Text] [Related]
38. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
Lim S
Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
[TBL] [Abstract][Full Text] [Related]
39. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
Parving HH
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
[No Abstract] [Full Text] [Related]
40. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
Tocci G; Sciarretta S; Facciolo C; Volpe M
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
